Clinical Trials Directory

Trials / Conditions / Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity

Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity

16 registered clinical trials studyying Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity.

StatusTrialSponsorPhase
CompletedCirculating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV No
NCT02245100
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University—
CompletedSorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell C
NCT02035527
Ohio State University Comprehensive Cancer CenterPhase 1
WithdrawnEntolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Ra
NCT01728480
Roswell Park Cancer InstitutePhase 1
CompletedPI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
NCT01816984
University of ChicagoPhase 1 / Phase 2
TerminatedTalactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Hea
NCT01528137
Stanford UniversityPhase 1
CompletedTLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squam
NCT01334177
University of WashingtonPhase 1
CompletedPhase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab
NCT00939627
National Cancer Institute (NCI)Phase 2
CompletedCetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cance
NCT01637194
Fox Chase Cancer CenterPhase 1
CompletedDasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
NCT00507767
National Cancer Institute (NCI)Phase 2
CompletedSaracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
NCT00513435
National Cancer Institute (NCI)Phase 2
CompletedBortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell
NCT00103259
National Cancer Institute (NCI)Phase 2
CompletedLapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
NCT00114283
National Cancer Institute (NCI)Phase 2
CompletedSB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
NCT00095628
National Cancer Institute (NCI)Phase 2
CompletedS0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
NCT00096512
National Cancer Institute (NCI)Phase 2
CompletedGefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Can
NCT00068497
National Cancer Institute (NCI)N/A
CompletedIxabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck
NCT00033618
National Cancer Institute (NCI)Phase 2